Herrero MJ - Search Results

1

Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.

Rojas LE, Herrero MJ, Bosó V, García-Eliz M, Poveda JL, Librero J, Aliño SF. Rojas LE, et al. Among authors: herrero mj. Pharmacogenet Genomics. 2013 Oct;23(10):509-17. doi: 10.1097/FPC.0b013e3283642fb3. Pharmacogenet Genomics. 2013. PMID: 23873120 Review.

2

Pig liver gene therapy by noninvasive interventionist catheterism.

Aliño SF, Herrero MJ, Noguera I, Dasí F, Sánchez M. Aliño SF, et al. Among authors: herrero mj. Gene Ther. 2007 Feb;14(4):334-43. doi: 10.1038/sj.gt.3302873. Epub 2006 Oct 12. Gene Ther. 2007. PMID: 17036058

3

Antigens and cytokine genes in antitumor vaccines: the importance of the temporal delivery sequence in antitumor signals.

Herrero MJ, Botella R, Dasí F, Algás R, Sánchez M, Aliño SF. Herrero MJ, et al. Ann N Y Acad Sci. 2006 Dec;1091:412-24. doi: 10.1196/annals.1378.084. Ann N Y Acad Sci. 2006. PMID: 17341632

4

The DD genotype of the angiotensin converting enzyme gene independently associates with CMR-derived abnormal microvascular perfusion in patients with a first anterior ST-segment elevation myocardial infarction treated with thrombolytic agents.

Bodi V, Sanchis J, Nunez J, Aliño SF, Herrero MJ, Chorro FJ, Mainar L, Lopez-Lereu MP, Monmeneu JV, Oltra R, Chaustre F, Forteza MJ, Husser O, Riegger GA, Llacer A. Bodi V, et al. Among authors: herrero mj. Thromb Res. 2009 Dec;124(6):e56-61. doi: 10.1016/j.thromres.2009.07.009. Epub 2009 Aug 7. Thromb Res. 2009. PMID: 19664801

5

Influence of pharmacogenetic polymorphisms in routine immunosuppression therapy after renal transplantation.

Herrero MJ, Sánchez-Plumed J, Galiana M, Bea S, Marqués MR, Aliño SF. Herrero MJ, et al. Transplant Proc. 2010 Oct;42(8):3134-6. doi: 10.1016/j.transproceed.2010.05.122. Transplant Proc. 2010. PMID: 20970628

6

Clinical interest of pharmacogenetic polymorphisms in the immunosuppressive treatment after heart transplantation.

Herrero MJ, Almenar L, Jordán C, Sánchez I, Poveda JL, Aliño SF. Herrero MJ, et al. Transplant Proc. 2010 Oct;42(8):3181-2. doi: 10.1016/j.transproceed.2010.05.129. Transplant Proc. 2010. PMID: 20970643

7

Analysis of metabolic and gene expression changes after hydrodynamic DNA injection into mouse liver.

Herrero MJ, Monleon D, Morales JM, Mata M, Serna E, Aliño SF. Herrero MJ, et al. Biol Pharm Bull. 2011;34(1):167-72. doi: 10.1248/bpb.34.167. Biol Pharm Bull. 2011. PMID: 21212539 Free article.

8

DNA delivery to 'ex vivo' human liver segments.

Herrero MJ, Sabater L, Guenechea G, Sendra L, Montilla AI, Abargues R, Navarro V, Aliño SF. Herrero MJ, et al. Gene Ther. 2012 May;19(5):504-12. doi: 10.1038/gt.2011.144. Epub 2011 Oct 13. Gene Ther. 2012. PMID: 21993175

9

Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients.

March-Villalba JA, Martínez-Jabaloyas JM, Herrero MJ, Santamaría J, Aliño SF, Dasí F. March-Villalba JA, et al. Among authors: herrero mj. Expert Opin Biol Ther. 2012 Jun;12 Suppl 1:S69-77. doi: 10.1517/14712598.2012.685716. Epub 2012 May 5. Expert Opin Biol Ther. 2012. PMID: 22559196

10

Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics.

March-Villalba JA, Martínez-Jabaloyas JM, Herrero MJ, Santamaria J, Aliño SF, Dasí F. March-Villalba JA, et al. Among authors: herrero mj. PLoS One. 2012;7(8):e43470. doi: 10.1371/journal.pone.0043470. Epub 2012 Aug 20. PLoS One. 2012. PMID: 22916267 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters